APA (7th ed.) Citation

X, L., F, Y., N, H., M, Z., Y, L., Y, Y., . . . Y, C. (2023). YM155 inhibits neuroblastoma growth through degradation of MYCN: A new role as a USP7 inhibitor. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 181, 106343. https://doi.org/10.1016/j.ejps.2022.106343

Chicago Style (17th ed.) Citation

X, Li, et al. "YM155 Inhibits Neuroblastoma Growth Through Degradation of MYCN: A New Role as a USP7 Inhibitor." European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences 181 (2023): 106343. https://doi.org/10.1016/j.ejps.2022.106343.

MLA (9th ed.) Citation

X, Li, et al. "YM155 Inhibits Neuroblastoma Growth Through Degradation of MYCN: A New Role as a USP7 Inhibitor." European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, vol. 181, 2023, p. 106343, https://doi.org/10.1016/j.ejps.2022.106343.